This grant opportunity (PAR-25-069) from the NIH seeks research proposals to investigate the mechanisms by which incretin mimetics impact cancer risk. The funding is available through CFDA 93.393 and supports R01 clinical trials (optional).
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.